Biqiang Zhu

557 total citations
13 papers, 427 citations indexed

About

Biqiang Zhu is a scholar working on Molecular Biology, Infectious Diseases and Physiology. According to data from OpenAlex, Biqiang Zhu has authored 13 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Physiology. Recurrent topics in Biqiang Zhu's work include Gut microbiota and health (4 papers), Cancer Mechanisms and Therapy (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). Biqiang Zhu is often cited by papers focused on Gut microbiota and health (4 papers), Cancer Mechanisms and Therapy (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). Biqiang Zhu collaborates with scholars based in China, Spain and Australia. Biqiang Zhu's co-authors include Lei Zhao, Fuya Zhao, Yunwei Wei, Jing Feng, Yunwei Wei, Yang Liu, Ye Jin, Jun Li, Jiayu Sun and Jing Feng and has published in prestigious journals such as Environmental Microbiology, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research and The International Journal of Biochemistry & Cell Biology.

In The Last Decade

Biqiang Zhu

13 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Biqiang Zhu China 10 256 83 72 55 53 13 427
Saif Abdul-Majeed Malaysia 8 253 1.0× 57 0.7× 43 0.6× 60 1.1× 38 0.7× 8 459
Antonia Feola Italy 13 250 1.0× 38 0.5× 87 1.2× 36 0.7× 39 0.7× 32 573
Lisa Mayr Austria 10 196 0.8× 53 0.6× 50 0.7× 85 1.5× 79 1.5× 18 431
Xianlong Ye China 12 263 1.0× 41 0.5× 41 0.6× 64 1.2× 41 0.8× 28 425
Inga C. Teller Netherlands 14 245 1.0× 54 0.7× 170 2.4× 66 1.2× 77 1.5× 17 682
Junbin Yan China 10 222 0.9× 61 0.7× 56 0.8× 79 1.4× 41 0.8× 24 493
Xueming Zhang China 11 170 0.7× 83 1.0× 37 0.5× 22 0.4× 30 0.6× 23 405
Lianyi Guo China 11 242 0.9× 59 0.7× 76 1.1× 46 0.8× 73 1.4× 30 531
Samira Asghari Iran 10 289 1.1× 77 0.9× 49 0.7× 21 0.4× 30 0.6× 18 517

Countries citing papers authored by Biqiang Zhu

Since Specialization
Citations

This map shows the geographic impact of Biqiang Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biqiang Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biqiang Zhu more than expected).

Fields of papers citing papers by Biqiang Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Biqiang Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biqiang Zhu. The network helps show where Biqiang Zhu may publish in the future.

Co-authorship network of co-authors of Biqiang Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Biqiang Zhu. A scholar is included among the top collaborators of Biqiang Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Biqiang Zhu. Biqiang Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Zhu, Biqiang, Fan Li, Jiajun Yu, et al.. (2024). PIEZO1 mediates matrix stiffness-induced tumor progression in kidney renal clear cell carcinoma by activating the Ca2+/Calpain/YAP pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1872(1). 119871–119871. 10 indexed citations
2.
Zhu, Biqiang, Jingjing Zheng, Gaichao Hong, et al.. (2022). L-Fucose inhibits the progression of cholangiocarcinoma by causing microRNA-200b overexpression. Chinese Medical Journal. 135(24). 2956–2967. 4 indexed citations
3.
Xu, Li, et al.. (2022). [Characteristics of liver function changes in 111 elderly patients with COVID-19 pneumonia].. PubMed. 30(5). 527–533. 1 indexed citations
4.
Zhu, Biqiang, Wei Qian, Chaoqun Han, Tao Bai, & Xiaohua Hou. (2021). Piezo 1 activation facilitates cholangiocarcinoma metastasis via Hippo/YAP signaling axis. Molecular Therapy — Nucleic Acids. 24. 241–252. 34 indexed citations
5.
Sun, Jiayu, Fuya Zhao, Baiqiang Lin, et al.. (2020). Gut Microbiota Participates in Antithyroid Drug Induced Liver Injury Through the Lipopolysaccharide Related Signaling Pathway. Frontiers in Pharmacology. 11. 598170–598170. 25 indexed citations
6.
Zhu, Biqiang & Yunwei Wei. (2019). Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway. Cancer Medicine. 9(2). 783–796. 35 indexed citations
7.
Zhu, Biqiang, Lei Zhao, Yang Liu, et al.. (2019). Induction of phosphatase shatterproof 2 by evodiamine suppresses the proliferation and invasion of human cholangiocarcinoma. The International Journal of Biochemistry & Cell Biology. 108. 98–110. 25 indexed citations
8.
Chen, Di, Yi Li, Hua Sun, et al.. (2019). P854 Insights into alteration of gut microbiota in inflammatory bowel disease patients with and without Clostridium difficile infection. Journal of Crohn s and Colitis. 13(Supplement_1). S551–S552. 3 indexed citations
9.
Zhao, Fuya, Jing Feng, Jun Li, et al.. (2018). Alterations of the Gut Microbiota in Hashimoto's Thyroiditis Patients. Thyroid. 28(2). 175–186. 152 indexed citations
10.
Zhu, Biqiang, Lei Zhao, Yang Liu, et al.. (2018). Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma. Cellular Physiology and Biochemistry. 47(2). 641–653. 61 indexed citations
11.
Jin, Ye, Yang Liu, Lei Zhao, et al.. (2018). Gut microbiota in patients after surgical treatment for colorectal cancer. Environmental Microbiology. 21(2). 772–783. 27 indexed citations
12.
Zhao, Lei, Jun Li, Yang Liu, et al.. (2017). Cholesterol Esterification Enzyme Inhibition Enhances Antitumor Effects of Human Chimeric Antigen Receptors Modified T Cells. Journal of Immunotherapy. 41(2). 45–52. 40 indexed citations
13.
He, Xiaoqiao, et al.. (2011). Study on a seawater hydraulic piston pump with check valves for underwater tools. Proceedings of the Institution of Mechanical Engineers Part A Journal of Power and Energy. 226(1). 151–160. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026